The U.S. Food and Drug Administration today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes.
Findings suggest potential anti-obesity use and novel drug for treating type 2 diabetes
Type 1 diabetes is not predominantly a ‘disease of childhood’ as previously believed, but is similarly prevalent in adults, new research published in the Lancet Diabetes & Endocrinology shows.
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living with type 1 diabetes.
Researchers at the University of Cambridge have taken the first step towards developing a new form of treatment for type 1 diabetes which, if successful, could mean an end to the regular insulin injections endured by people affected by the disease, many of whom are children.